18F-Fluorodeoxyglucose PET scans in lung cancer

Thorax

Volumn 51, Issue SUPPL. 2, 1996, Pages

  Hughes, J M B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; LUNG TUMOR; METABOLISM; REVIEW;

DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030208503     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.Suppl_2.S16     Document Type: Article

References (34)

1. Chin R, Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-6.
2. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer: approaching a controversy using meta-analysis. Am Rev Respir Dis 1990;141:1096-101.
3. 14C deoxyglucose methods for the measurement of local cerebral glucose utilization in man. J Neurochem 1977;28:897-916.
4. Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993;72:82-90.
5. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60:2682-9.
6. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
7. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987;235:1492-5.
8. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987;235:1495.
9. Monakhov NK, Neistadt EL, Shavlovskil MM. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978;67:27-34.
10. Jones HA, Clark RJ, Rhodes CG, Schofield JB, Krausz T, Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994;149:1635-9.
11. Jones HA, Sriskandan S, Peters AM, Krausz T, Pride NB, Haslett C. Metabolic activity of neutrophils is distinct from migration in lobar pneumonia and bronchiectasis. Am J Respir Crit Care Med 1995;151: A343.
12. Brudin LH, Valind SO, Rhodes CG, et al. Regional glucose uptake in patients with sarcoidosis. Eur J Nucl Med 1994;21:297-305.
13. Pantin CF, Valind SO, Sweatman M, et al. Measures of the inflammatory response in cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1988; 138:1234-41.
14. Kubota R, Yamada S, Kubota K. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
15. Brown SR, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 1993;34:75-82.
16. Scott WJ, Schwabe JL, Gupta NC, Dewan NA, Reeb SD, Sugimoto JT. Positron emission tomography of lung tumours and mediastinal lymph nodes using [18F]fluorodeoxyglucose. Am Thorac Surg 1994; 58:698-703.
17. Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun 1993;14:955-61.
18. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993;104:997-1002.
19. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-4.
20. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-32.
21. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-90.
22. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 1995; 108:441-6.
23. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography. J Thorac Cardiovasc Surg 1995;110:130-9.
24. Hubner KF, Buonocore E, Singh SK, Gould HR, Cotten DW. Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med 1995;20:293-8.
25. Sazon DAD, Siverio SM, Soo Hoo GW, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996;153:417-21.
26. Langen KJ, Braun U, Rota-Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucase uptake in bronchial carcinomas. J Nucl Med 1993;34:355-9.
27. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalanen U, Joensuu H. Influence of blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993;34:1-6.
28. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-7.
29. 18FDG in patients with bronchogenic carcinoma. Chest 1995;108:1617-21.
30. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127:659-64.
31. Lewis P, Griffin S, Marsden P, et al. Whole-body 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994;344:1265-6.
32. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1994;191:379-82.
33. Frank A, Lefkowitz D, Jaeger S, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings, Int J Radiat Oncol Biol Phys 1995;32:1495-512.
34. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36:788-93.